Identification

Symbol
AB
ISIN code
FR0010557264
Exchange / Market
Euronext Growth
Trading location
Paris
ICB
Biotechnology
Activity description

AB Science is a pharmaceutical company specializing in the discovery, development and commercialization of novel targeted therapies named protein kinase inhibitors. Our target diseases are cancers, inflammatory diseases, with high unmet medical need in both human and veterinary medicine. AB Science was created in 2001. The company is headquartered in Paris and has a subsidiary in the USA.

Website address
http://www.ab-science.com
Issuer website
http://www.ab-science.com

Operation

IPO date
Wed 21/04/2010
IPO type
Initial Public offering
Catégorie
IPO